Clinical Trials in Nashville

Showing 11741-11760 of 17,403 trials

Phase I Dose Escalation of Oral BAY1161909 in Combination With Intravenous Paclitaxel

NCT02138812

Determine the safety, tolerability, maximum tolerated dose (MTD), and recommended Phase II dose (RP2D) of BAY1161909 in combination with paclitaxel in subjects with advanced malignancies.

Medical Oncology

Bayer69 participantsStarted May 2014

Santa Monica, California, United States • New Haven, Connecticut, United States • Boston, Massachusetts, United States +3 more locations

COMPLETEDPhase 4< 1 mile

Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings

NCT00084136

This study compared 3 different three-drug combinations in HIV infected individuals starting their first HIV treatment regimens. Participants were recruited from resource-limited areas in Africa, Asia, South America, Haiti, and also from the United States. The study hypothesis was each of the once daily combinations (PI based, or NNRTI based) would not have inferior efficacy compared to the twice daily NNRTI based combination.

HIV Infections

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections1,571 participantsStarted May 2005

Los Angeles, California, United States • Los Angeles, California, United States • Torrance, California, United States +39 more locations

Phase I Dose Escalation of Oral BAY1161909 in Combination With Intravenous Paclitaxel

Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings

Find Trials by Condition in Nashville

Alisertib and Combination Chemotherapy in Treating Patients With Gastrointestinal Tumors

Substance Abuse Treatment to HIV Care (SAT2HIV): The Implementation & Sustainment Facilitation Experiment

Gastric Electrical Stimulation (GES) for the Treatment of Obesity

A Study of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Stage I and Stage II Hypertension

A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Safety and Immunogenicity of 2 or 3 Doses of MenACWY Conjugate Vaccine in Healthy Infants and the Effects of a Booster Dose of MenACWY Administered in the Second Year of Life

Multicenter Continuous Peripheral Nerve Block Surveillance Study

A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.

A Study to Evaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Associated With Chronic Kidney Diseases (CKD)

Triathlon® Cruciate Retaining (CR) Total Knee System Outcomes Study

Sevelamer for Reducing Endotoxemia and Immune Activation

Open-label Long-term Safety Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease Who Have Completed a Previous AT1001 Study

Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas

Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease

Post-Market Study of the Modular Revision Hip System

A Study of Axitinib in Advanced Carcinoid Tumors

Safety, Efficacy, Dose-finding Study of a Monoclonal Antibody in Patients With Multiple Myeloma

A Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris